At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 46 enrolled
Drug / intervention
Statin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Endothelium Dysfunction in Patients of Obstructive Sleep Apnea Syndrome
In Brief
A Phase 4 clinical trial evaluating CPAP and Statin for Sleep Apnea, Obstructive. Completed, enrolled 46 participants across 1 site.
Detailed Summary
study Hypothesis: We hypothesize that CPAP could effectively improve the endothelial dysfunction by anti-inflammatory effect in patients of OSA,and compare to the effect of statin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSleep Apnea, Obstructive
CountriesTaiwan
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2010
First PostedOct 2012
Primary CompletionFeb 2013
Study CompletionAug 2013
TodayJul 2026
First PostedOct 3, 2012
Enrollment StartMay 1, 2010
Primary CompletionFeb 1, 2013
Study CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 13.7 years ago
Interventions
CPAPdevice
Continuous Positive Airway Pressure is the routine treatment of OSA, patients will be randomly assigned into CPAP treatment group
Statindrug
Statin is an lipid lowering medication with anti-inflammatory effect.